Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biontech Se ADR
(NQ:
BNTX
)
88.19
+0.96 (+1.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biontech Se ADR
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
54
55
Next >
Researchers Working On Universal mRNA-Influenza Vaccine Aiming For Baseline Immune Memory For Diverse Strains
November 25, 2022
Researchers are working on an experimental pan-influenza vaccine based on the famed mRNA technology to provide broad protection.
Via
Benzinga
Is Now the Time for Income Investors to Buy This Big Pharma Stock?
November 24, 2022
This drugmaker is among the most dominant pharmaceutical companies in the world.
Via
The Motley Fool
7 Stocks on the Perfect 10 List
November 23, 2022
Companies that have strong quality, value, or growth grades are the stocks to buy once markets recognize their business potential.
Via
InvestorPlace
PFE Stock Could Be the Booster Shot Your Portfolio Needs Now
November 23, 2022
PFE stock still remains a dirt-cheap dividend darling, even after across-the-board earnings beats and lifted guidance.
Via
InvestorPlace
Jim Cramer Says China's Vaccines 'Don't Work' But Xi Won't Admit It
November 22, 2022
COVID-19 cases have spiked again in China, sparking fresh lockdown measures in the nation's capital. Jim Cramer has suggested that Chinese President Xi Jinping isn't telling the whole story.
Via
Benzinga
This COVID-19 Vaccine Stock Has More to Offer
November 10, 2022
The vaccine revenue was nice, but it's time to look ahead.
Via
The Motley Fool
BioNTech SE (BNTX) Q3 2022 Earnings Call Transcript
November 07, 2022
BNTX earnings call for the period ending September 30, 2022.
Via
The Motley Fool
2 Reasons to Buy Pfizer and 1 Reason to Sell
November 20, 2022
The pharmaceutical company is looking for a future beyond COVID-19 therapies.
Via
The Motley Fool
After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade
November 18, 2022
Bill Gates has two portfolios he makes trades from: the Bill & Melinda Gates Foundation and the Bill & Melinda Gates Foundation Trust.
Via
Benzinga
7 Stocks to Sell Right Now… and 1 to Buy
November 18, 2022
Although red ink can sometimes bring an opportunity for contrarianism, these (except one) market ideas represent stocks to sell.
Via
InvestorPlace
Pfizer/BioNTech's Omicron Tailored COVID-19 Vaccine Shows Improved Immune Response Against Emerging Omicron Sublineages
November 18, 2022
Via
Benzinga
Market Rally Holds Key Levels, But Breakouts Struggle; Walmart, Target, Nvidia In Focus: Weekly Review
November 18, 2022
Walmart, Target and Nvidia were key earnings movers.
Via
Investor's Business Daily
Pfizer, BioNTech Take Next Step Toward A Pan-Covid Vaccine — But Is The Demand There?
November 17, 2022
The biggest question facing the shot is whether there will be demand for it.
Via
Investor's Business Daily
Ukraine Asserts It Does Not Take Blame For Poland Missile Attack, Crypto Exchange Gemini Suffers $485M In Outflows, FTX, Bahamas Regulator Lock Horns Over Control Of Bankruptcy Proceedings: Top Stories Thursday, Nov. 17
November 17, 2022
CNBC
Via
Benzinga
Pfizer, BioNTech Start Work On Next-Gen COVID-19 Vaccine Candidate For Broader Protection
November 17, 2022
Via
Benzinga
Third COVID-19 Booster or Fifth Dose Not Required Despite Surge In Cases, Australian Health Authorities Say
November 15, 2022
Australian health authorities have recommended against a fifth COVID-19 vaccine shot despite average daily cases having been 47% higher last week than the week before, said Health Minister Mark Butler...
Via
Benzinga
Moderna Surges On New Omicron Data, Pulling Pfizer, BioNTech Along For The Ride
November 14, 2022
Its booster led to a 15.1-fold increase in BA.4- and BA.5-blocking antibodies.
Via
Investor's Business Daily
BioNTech Plans To Set Up Singapore Based mRNA Plant By End Of 2023
November 14, 2022
Via
Benzinga
Repeat COVID-19 Infection Increases Risk Of Acute Outcomes, Long COVID Symptoms, Study Shows
November 11, 2022
Via
Benzinga
Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?
November 10, 2022
By Ernest Dela Aglanu, Benzinga
Via
News Direct
Exposures
COVID-19
Product Safety
Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster
November 10, 2022
Via
Benzinga
2 Top Healthcare Stocks to Buy Right Now
November 10, 2022
These two dividend stocks offer 3%-plus dividend yields that are secure.
Via
The Motley Fool
Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?
November 10, 2022
During the peak of the deadly COVID-19 pandemic, one novel therapeutic that seems to have played an important role in helping save lives was Organicell Regenerative Medicine Inc.’s (OTCMKTS:...
Via
Benzinga
Return To Office: Pfizer To Enforce 2-3 Days In Office Starting January
November 09, 2022
Pfizer Inc's (NYSE: PFE) CEO Albert Bourla said the U.S. employees would have to return to their workplaces two to three days a week starting in January.
Via
Benzinga
The 7 Best Pharma Stocks to Buy Now
November 08, 2022
Investors searching for gains in the current market storm should consider taking a position in some of the best pharma stocks.
Via
InvestorPlace
Got $2,000? 2 Fantastic Stocks to Buy No Matter What the Market Does Next
November 08, 2022
These stocks both have non-cyclical businesses that can drive growth in a wide variety of markets.
Via
The Motley Fool
BioNTech Takes A Hit Despite Doubling Profit Views, Raising 2022 Outlook
November 07, 2022
BioNTech doubled profit expectations in the third quarter and raised its outlook.
Via
Investor's Business Daily
Meta Goes Twitter Way With Layoffs, Twitter Might Want Some People Back After Firing Them, Coal Miners Terminate $6B Combination Discussions: Top Stories Monday, Nov. 07
November 07, 2022
Wall Street Journal
Via
Benzinga
BioNTech Posts About 50% Drop In Q3 Sales and Profits Amid Falling Demand For COVID-19 Shots
November 07, 2022
Via
Benzinga
Risk Appetites Survive China Keeping Zero COVID Policy
November 07, 2022
Chinese officials denied plans to end the zero-COVID policy and after a brief wobble, risk assets have traded better. Asia Pacific equities rallied, led by Hong Kong and mainland stocks that trade in...
Via
Talk Markets
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
54
55
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.